Colgate-Palmolive (CL) Tops Q2 EPS by 2c, Beats on Revenue

Colgate-Palmolive (NYSE: CL) reported Q2 EPS of $0.77, $0.02 better than the analyst estimate of $0.75. Revenue for the quarter came in at $4.82 billion versus the consensus estimate of $4.68 billion.

The company guides:

• The Company now expects net sales growth to be 5% to 8% including the benefit from our acquisitions of pet food businesses and a low-single-digit negative impact from foreign exchange.
• The Company now expects organic sales growth to be 5% to 7%.
• On a GAAP basis, the Company still expects gross profit margin expansion, increased advertising investment and double-digit earnings-per-share growth.
• On a non-GAAP (Base Business) basis, the Company still expects gross profit margin expansion and increased advertising investment and now expects earnings-per-share growth to be at the high end of mid-single-digits

For earnings history and earnings-related data on Colgate-Palmolive (CL) click here.

You May Also Be Interested In

• Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• MeiraGTx Holdings plc (MGTX) Tops Q2 EPS by 202c